Genes that control hepatic treatment and VLDL secretion mutations are involved in familial causes of NAFLD [36], Romeo et al. [23] reported that NAFLD is associated with the rs738409 polymorphism in PNPLA3. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.